Medexus Pharmaceuticals Inc
TSX:MDP

Watchlist Manager
Medexus Pharmaceuticals Inc Logo
Medexus Pharmaceuticals Inc
TSX:MDP
Watchlist
Price: 2.74 CAD 3.01% Market Closed
Market Cap: 88.8m CAD

Wall Street
Price Targets

MDP Price Targets Summary
Medexus Pharmaceuticals Inc

Wall Street analysts forecast MDP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDP is 6.3 CAD with a low forecast of 3.48 CAD and a high forecast of 8.4 CAD.

Lowest
Price Target
3.48 CAD
27% Upside
Average
Price Target
6.3 CAD
130% Upside
Highest
Price Target
8.4 CAD
207% Upside
Medexus Pharmaceuticals Inc Competitors:
Price Targets
4746
Formosa Laboratories Inc
74% Upside
2005
SSY Group Ltd
37% Upside
000520
Samil Pharmaceutical Co Ltd
28% Upside
MANKIND
Mankind Pharma Ltd
21% Upside
NEULANDLAB
Neuland Laboratories Ltd
43% Upside
AZN
AstraZeneca PLC
6% Upside
003850
Boryung Corp
31% Upside
200670
Humedix Co Ltd
64% Upside

Revenue
Forecast

Revenue Estimate
Medexus Pharmaceuticals Inc

For the last 12 years the compound annual growth rate for Medexus Pharmaceuticals Inc's revenue is 37%. The projected CAGR for the next 3 years is 4%.

37%
Past Growth
4%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Medexus Pharmaceuticals Inc

The compound annual growth rate of Medexus Pharmaceuticals Inc's operating income for the next 3 years is 24%.

N/A
Past Growth
24%
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Medexus Pharmaceuticals Inc

The compound annual growth rate of Medexus Pharmaceuticals Inc's net income for the next 3 years is 86%.

N/A
Past Growth
86%
Estimated Growth
Estimates Accuracy
-22%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDP's stock price target?
Price Target
6.3 CAD

According to Wall Street analysts, the average 1-year price target for MDP is 6.3 CAD with a low forecast of 3.48 CAD and a high forecast of 8.4 CAD.

What is Medexus Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
4%

For the last 12 years the compound annual growth rate for Medexus Pharmaceuticals Inc's revenue is 37%. The projected CAGR for the next 3 years is 4%.

What is Medexus Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
24%

The compound annual growth rate of Medexus Pharmaceuticals Inc's operating income for the next 3 years is 24%.

What is Medexus Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
86%

The compound annual growth rate of Medexus Pharmaceuticals Inc's net income for the next 3 years is 86%.

Back to Top